MorphoSys ADR earnings, Revenue miss in Q1

  • Investing.com
MorphoSys ADR earnings, Revenue miss in Q1

Investing.com - MorphoSys ADR reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.

MorphoSys ADR announced earnings per share of €-3.59 on revenue of €41.5M. Analysts polled by Investing.com anticipated EPS of €-0.911 on revenue of €46.88M.

MorphoSys ADR shares are down 42.57% from the beginning of the year and are trading at €5.41 , down-from-52-week-high.They are under-performing the Nasdaq which is down 17.13% year to date.

MorphoSys ADR follows other major Healthcare sector earnings this month

MorphoSys ADR's report follows an earnings beat by UnitedHealth on Thursday, April 14, 2022, who reported EPS of €5.49 on revenue of €80.15B, compared to forecasts EPS of €5.36 on revenue of €78.73B.

J&J had beat expectations on Tuesday, April 19, 2022 with first quarter EPS of €2.67 on revenue of €23.43B, compared to forecast for EPS of €2.59 on revenue of €23.62B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles